Trial Profile
Effects of Basal Insulin Analogue Detemir on Body Composition, Epicardial Fat and Energy Metabolism.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 06 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov..
- 03 Sep 2013 Planned End Date changed from 1 Dec 2011 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 21 Mar 2009 New trial record